Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of Melphalan and BUCY+VP-16
myeloablative conditioning regimens in multiple myeloma undergoing autologous hematopoietic
stem cell transplantation.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Nanfang Hospital of Southern Medical University
Collaborators:
Guangzhou First People's Hospital Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Third Affiliated Hospital, Sun Yat-Sen University Zhujiang Hospital